Cargando…
4053 A TL1 Team Approach to CNS-Localized Delivery of Glial Cell-Derived Neurotrophic Factor for Treatment of Parkinson’s Disease
OBJECTIVES/GOALS: Develop a strategy to restrict GDNF diffusion at an injected CNS tissue site for dopamine neuron rescue by endowing it with binding affinity for carbohydrates that are abundant on the cell surface and extracellular matrix. METHODS/STUDY POPULATION: GDNF will be fused to galectin-3...
Autores principales: | Farhadi, Shaheen, Gopinath, Adithya, Streit, Wolfgang, Hudalla, Gregory A, Khoshbouei, Habibeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798131/ http://dx.doi.org/10.1017/cts.2020.49 |
Ejemplares similares
-
3475 A TL1 Team Approach to CNS-Localized Delivery of Neurotrophic Factors for Treatment of Parkinson’s Disease
por: Gopinath, Adithya, et al.
Publicado: (2019) -
30580 A TL1 Approach to Assessing Peripheral Immune Changes in PTSD
por: Mackie, P. M., et al.
Publicado: (2021) -
DAT and TH expression marks human Parkinson’s disease in peripheral immune cells
por: Gopinath, Adithya, et al.
Publicado: (2022) -
2090 TL1 team approach to osteosarcoma cell detection
por: Dopico, Pablo J., et al.
Publicado: (2018) -
Methamphetamine neurotoxicity, microglia, and neuroinflammation
por: Shaerzadeh, Fatemeh, et al.
Publicado: (2018)